Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic
Efficacy of Tramadol Hcl in the Treatment of Renal Colic
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute renal colic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2006
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2006
CompletedFirst Posted
Study publicly available on registry
April 5, 2006
CompletedStudy Start
First participant enrolled
September 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedFebruary 17, 2009
September 1, 2006
2.4 years
April 4, 2006
February 15, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain improvement according to VAS score at 30, 60 and 120 minutes(Stage I)
30, 60, 120 minutes
Need for rescue medication at 30 minutes (Stage I)
30 minutes
Pain improvement according to VAS score at 24 and 48 hrs (Stage II)
24 and 48 hrs
Interventions
Active Comparator
Eligibility Criteria
You may qualify if:
- Patients with clinical diagnosis of acute renal colic (Stage I)
- Patients with diagnosed renal colic who might need prevention of pain and are able to swallow medicines (Stage II)
You may not qualify if:
- Patients with known hypersensitivity to the study drugs
- Pregnancy or lactation
- Known renal failure or hepatic disease
- Concommitant drug use which could adversely affect patient's outcome (oral anticoagulant, MAO inhibitors)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadassah Medical Organizationlead
- Grumentalcollaborator
Study Sites (1)
Hadassah Medical Organization
Jerusalem, 12000, Israel
Related Publications (1)
Ukhal' MI, Melenevskii DA. [Using prostaglandin inhibitor dicloberl in patients with ureteral calculi]. Lik Sprava. 2004 Mar;(2):76-8. Russian.
PMID: 15208882RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ruth Stalnikowicz, MD
Hadassah Medical Organization
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 4, 2006
First Posted
April 5, 2006
Study Start
September 1, 2006
Primary Completion
February 1, 2009
Study Completion
February 1, 2009
Last Updated
February 17, 2009
Record last verified: 2006-09